Skip to main content
$84.87 $0.64 (0.8%)

04:15 PM EDT on 09/18/20

Catalent Inc. (NYSE:CTLT)

CAPS Rating: 5 out of 5

Current Price $84.87 Mkt Cap $14.0B
Open $0.00 P/E Ratio 73.49
Prev. Close $84.87 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 15,809,382
52-Wk Range $31.04 - $95.70 Avg. Daily Vol. 1,740,420


How do you think NYSE:CTLT will perform against the market?

Add Stock to CAPS Watchlist

All Players

24 Outperform
0 Underperform

All-Star Players

9 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NYSE:CTLT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ScalaAnalyst (< 20)
Submitted August 22, 2016

CTLT will report earnings on Aug 29,2016.They are expected to make 0.54 earnings per share. But, I believe this is a solid company and they will beat expected street earnings.They are a new company having come from their IPO back in Nov, 2014, but… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!



Fools bullish on NYSE:CTLT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about CTLT.


Member Avatar DMahoney0915 (< 20) Submitted: 7/29/2020 8:53:19 AM : Outperform Start Price: $83.04 NYSE:CTLT Score: -1.23

Given the partnerships created for COVID vaccine lineups, there is little to no chance they won't see significant financial gains. Whether the vaccines struggle from storage and logistical issues, Catalent is poised to provide supply to meet a pandemic driven demand.


Member Avatar XMFBlacknGoldX (95.59) Submitted: 10/3/2019 11:11:04 AM : Outperform Start Price: $50.87 NYSE:CTLT Score: +55.41

From 09/17/2019:

"Catalent isn't a household name, and isn't even a well-known name among gene therapy stocks. But investors interested in the potential of corrective or curative genetic medicines shouldn't overlook the stock. The recent acquisition of Paragon Bioservices immediately made Catalent one of the most important companies in the space. Its growing list of customers are certainly aware of that, and it may only be a matter of time before Wall Street catches on."


Member Avatar ScalaAnalyst (< 20) Submitted: 8/22/2016 7:32:14 PM : Outperform Start Price: $24.78 NYSE:CTLT Score: +187.77

CTLT will report earnings on Aug 29,2016.

They are expected to make 0.54 earnings per share. But, I believe this is a solid company and they will beat expected street earnings.

They are a new company having come from their IPO back in Nov, 2014, but they have a lot a room for growth. This might be a good stock to review as the biotech stocks as a group are down.

The health care products will be in demand as long as America continues to age. They have been beaten down from a 52 week high of 32/sh. But what company hasn't

They have have increases in their Revenue growth and their Cash Flow. This might be a stock to look into.


Find the members with the highest scoring picks in CTLT.

Score Leader


boothjp21 (< 20) Score: +250.41

The Score Leader is the player with the highest score across all their picks in CTLT.

Member Name Member
Call Time
Score Commentary
boothjp21 < 20 8/1/2014 Outperform 5Y $19.98 +321.52% +71.11% +250.41 0 Comment
Shigo 40.11 9/8/2014 Outperform 5Y $22.35 +276.82% +64.57% +212.26 0 Comment
jmaryn 99.25 11/14/2014 Outperform 5Y $23.75 +254.61% +61.90% +192.71 0 Comment
ScalaAnalyst < 20 8/25/2016 Outperform 5Y $24.78 +239.87% +52.10% +187.77 1 Comment
popollli < 20 1/5/2015 Outperform 5Y $27.54 +205.81% +62.87% +142.94 0 Comment
portefeuille2 99.32 6/22/2015 Outperform 5Y $30.92 +172.38% +55.79% +116.59 0 Comment
SlowThought 47.22 8/25/2015 Outperform 5Y $31.62 +166.35% +69.19% +97.16 0 Comment
craftmacaroni 81.01 8/3/2015 Outperform 5Y $34.08 +147.12% +57.11% +90.02 0 Comment
MarcM 92.35 10/4/2017 Outperform 5Y $42.35 +98.89% +30.59% +68.30 0 Comment
drnetopsgolf 71.76 11/11/2019 Outperform 5Y $49.46 +70.28% +7.56% +62.72 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CTLT.